Cargando…
Multi-Omics Analysis of Gut Microbiota in Inflammatory Bowel Diseases: What Benefits for Diagnostic, Prognostic and Therapeutic Tools?
Inflammatory bowel diseases (IBDs), which include Crohn’s disease and ulcerative colitis, are multifactorial diseases that involve in particular a modification of the gut microbiota, known as dysbiosis. The initial sets of metataxonomic and metagenomic data first made it possible to approximate the...
Autores principales: | Lacroix, Vickie, Cassard, Alexis, Mas, Emmanuel, Barreau, Frederick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537481/ https://www.ncbi.nlm.nih.gov/pubmed/34681921 http://dx.doi.org/10.3390/ijms222011255 |
Ejemplares similares
-
The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease
por: Segal, Jonathan P., et al.
Publicado: (2019) -
Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome
por: Liu, Si, et al.
Publicado: (2019) -
Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
por: Mamieva, Zarina, et al.
Publicado: (2022) -
Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications
por: Del Chierico, Federica, et al.
Publicado: (2014) -
How Can a Polymeric Formula Induce Remission in Crohn’s Disease Patients?
por: Boumessid, Kawthar, et al.
Publicado: (2021)